home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Charting the Course: Strategies for Therapeutic Vaccine Study Success

 
  September 18, 2024  
     
 
Xtalks, Online
2024-10-09


Therapeutic vaccines have emerged as a promising approach in the field of immunotherapy, with researchers striving to discover and develop a new way to treat complex diseases such as cancer, human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

The development of therapeutic vaccines presents distinct considerations, challenges and opportunities that differ from those encountered in the development of preventative vaccines. This webinar aims to delve into these key differences and explore the intricacies involved in the conduct of clinical trials for therapeutic vaccines.

By exploring clinical and study design considerations, reviewing the historical and current research efforts, discussing advanced modalities and defining ideal clinical trial operations and project team setups, attendees will gain valuable insights into this rapidly evolving field.

This webinar explores the current research and rationale behind the use of vaccines as therapeutics, including advanced modalities such as messenger RNA (mRNA) and cell/gene therapies. Attendees will gain a foundational understanding of the top indications and challenges faced in therapeutic vaccine development and practical considerations for conducting clinical trials.

Read more...

Register for this webinar today to explore advancements in therapeutic vaccine development from tackling complex diseases like cancer and HIV to the innovative use of mRNA and cell and gene therapies.

Keywords: Vaccine, Virus, Drug Development, Clinical Research, CRO, Vaccines, Vaccine Development, Coronavirus, Virology, mRNA Vaccines, Basic Research
 
 
Organized by: Xtalks
Invited Speakers: Dr. Narcisa Mesaros, MD, VP, Medical Science & Strategy, Vaccines, PPD Clinical Research Business of Thermo Fisher Scientific
Dr. Jaikrishna Balkissoon, MD, FACS Global VP, Head Cell and Gene Therapy, PPD Clinical Research Business of Thermo Fisher Scientific
Mario Davinelli, Executive Director, Project Management, Vaccines, PPD Clinical Research Business of Thermo Fisher Scientific
 
Deadline for Abstracts: 2024-10-09
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.